D-1574-2014 Class II Terminated
FDA drug recall D-1574-2014 was initiated by Apotex Inc. on Mar 24, 2014 and is designated Class II. Reason for recall: Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents. The recall status is terminated (terminated Sep 23, 2014).
Recall details
- Product Type
- Drugs
- Report Date
- Sep 10, 2014
- Initiation Date
- Mar 24, 2014
- Termination Date
- Sep 23, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Paroxetine HCL Controlled-Release Tablets 12.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3673-3
Reason for recall
Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot # 2A001, Exp. 01/15 Lot # 2A002, Exp. 01/15 Lot # 2C003, Exp. 03/15 Lot # 2F005, Exp. 06/15 Lot # 2G006, Exp. 07/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1574-2014
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026